(株)カイノスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4556/E00977 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2021/08/13 | 日証協 | 122,300株 | -0.08% | 3,800株 | -91.52% | 157,216株 | +0.7% | 5,800株 | -17.15% |
| 2021/08/06 | 日証協 | 122,400株 | +8.13% | 44,800株 | -58.09% | 156,116株 | +4.98% | 7,001株 | -84.51% |
| 2021/07/30 | 日証協 | 113,200株 | +44.57% | 106,900株 | +176.94% | 148,715株 | +9.18% | 45,200株 | +109.26% |
| 2021/07/21 | 日証協 | 78,300株 | +21.21% | 38,600株 | +1654.55% | 136,215株 | +8.09% | 21,600株 | +332% |
| 2021/07/16 | 日証協 | 64,600株 | -0.62% | 2,200株 | -56% | 126,015株 | +3.96% | 5,000株 | -31.51% |
| 2021/07/09 | 日証協 | 65,000株 | 0% | 5,000株 | -24.24% | 121,215株 | +3.06% | 7,300株 | -67.41% |
| 2021/07/02 | 日証協 | 65,000株 | -18.34% | 6,600株 | -81.46% | 117,615株 | -5.08% | 22,400株 | +39.13% |
| 2021/06/25 | 日証協 | 79,600株 | +10.56% | 35,600株 | +78.89% | 123,915株 | +6.63% | 16,100株 | -0.62% |
| 2021/06/18 | 日証協 | 72,000株 | +28.57% | 19,900株 | +43.17% | 116,215株 | +2.56% | 16,200株 | -1.82% |
| 2021/06/11 | 日証協 | 56,000株 | -27.74% | 13,900株 | -88.01% | 113,315株 | -8.63% | 16,500株 | -83.15% |
| 2021/06/04 | 日証協 | 77,500株 | -36.21% | 115,900株 | -32.84% | 124,016株 | +1.61% | 97,915株 | -14.52% |
| 2021/05/28 | 日証協 | 121,500株 | +223.14% | 172,565株 | +9999.99% | 122,056株 | -6.05% | 114,541株 | +9999.99% |
| 2021/05/21 | 日証協 | 37,600株 | -10.05% | 400株 | -97.97% | 129,916株 | -0.92% | 1,000株 | -90.99% |
| 2021/05/14 | 日証協 | 41,800株 | +10.29% | 19,700株 | +9999.99% | 131,116株 | -1.36% | 11,100株 | +516.67% |
| 2021/05/07 | 日証協 | 37,900株 | -6.42% | 100株 | 0% | 132,927株 | +0.3% | 1,800株 | -50% |
| 2021/04/30 | 日証協 | 40,500株 | -6.25% | 0株 | -100% | 132,527株 | +0.76% | 3,600株 | +56.52% |
| 2021/04/23 | 日証協 | 43,200株 | -16.92% | 2,200株 | -66.67% | 131,527株 | -3.52% | 2,300株 | -45.24% |
| 2021/04/16 | 日証協 | 52,000株 | -25.07% | 6,600株 | -13.16% | 136,327株 | -11.61% | 4,200株 | +16.67% |
| 2021/04/09 | 日証協 | 69,400株 | -24.81% | 7,600株 | -71.1% | 154,227株 | -10.03% | 3,600株 | -96.37% |
※株式分割は考慮していませんのでご注意ください。
Page Top